Disulfide compounds for delivery of pharmaceutical agents
US9765022B2 · kind B2 · utility
2Cited by
0References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 28, 2014 |
| Grant date | Sep 19, 2017 |
| Priority date | — |
| Expiry date | Feb 28, 2034 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07B45/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A compound of formula the following formula: (I). In this formula, moieties A, B, X, R1, R2, and R3 are defined herein. Also disclosed are a nanocomplex that is formed of such a compound and a pharmaceutical agent, and a nanocomplex that is formed of a protein and a bioreducible compound.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.